Oakwood convinces third circuit to reopen TS suit

Oakwood Laboratories has convinced third circuit judges to revive a trade secrets dispute with its former vice president of product developments over microsphere drugs.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

CBD company faults sparse evidence in trade secrets spat

14 January 2021 Medical cannabis company Medterra and has hit back at claims it misappropriated trade secrets at a federal court in Florida, holding that the company alleging the IP violation had failed to produce sufficient evidence.

Big Pharma

Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute

5 November 2020 Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.

More features

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Oakwood convinces third circuit to reopen TS suit

More on this story

Editor's picks

Editor's picks

More features